Blood cell changes during heart surgery and their effect on recovery
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study looks at how blood cells change during heart surgery and whether these changes affect bleeding or inflammation after the operation. It may help doctors predict and manage complications in people having heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have coronary artery disease or a heart valve problem (mitral or aortic).
- You are scheduled for a coronary angiogram or heart surgery using a heart-lung machine.
- You are not taking two blood-thinning medicines without a break.
- You do not have certain blood disorders, liver problems, or a weakened immune system.
- You have not had recent major surgery, chemotherapy, or a heart attack in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well platelets work during heart surgery using a special test called thromboelastography. It may help doctors understand and manage bleeding risks in people having planned heart surgery with a heart-lung machine.
This study tests whether using your own donated platelets during heart surgery can help you recover better. Platelets are cells that help your blood clot, and donating them before surgery may reduce the need for donor blood.
This study looks at how much donated blood (blood products) is needed for younger adults during heart surgery that uses a heart-lung machine. It may help doctors choose safer, more appropriate blood-saving plans for people like you.
This study tests whether giving blood transfusions based on each patient's needs during and after heart surgery is safe and effective. It compares different transfusion thresholds to see which works better.
This study tests a new blood test that measures how well your blood forms clots. It aims to see if this test can predict bleeding after heart surgery that uses a heart-lung machine, which might help doctors manage bleeding better.
This trial tests whether giving back a patient's own platelets and red blood cells during heart surgery can reduce bleeding and the need for donor blood transfusions. It is for people having certain types of high-risk heart surgery with a heart-lung machine.
Hear when a new Cardiac Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.